Idiopathic juvenile osteoporosis
1Department of Endocrinology and Metabolism, Panagia General Hospital, Thessaloniki, Greece. krassas@the.forthnet.gr
Insights
Idiopathic juvenile osteoporosis (IJO) is a rare childhood condition with unknown causes, diagnosed by excluding other diseases. Treatment focuses on spinal protection, with therapies showing equivocal results as the condition typically resolves spontaneously.
Area of Science:
- Pediatrics
- Endocrinology
- Bone Metabolism
Background:
- Osteoporosis in children is rare and often secondary to other conditions.
- Idiopathic juvenile osteoporosis (IJO) is diagnosed when other causes are excluded, characterized by unknown etiology and bone fractures.
- Congenital conditions like osteogenesis imperfecta can also present with childhood osteoporosis.
Purpose of the Study:
- To review the characteristics and management of idiopathic juvenile osteoporosis (IJO).
- To highlight diagnostic criteria and treatment strategies for pediatric osteoporosis.
- To discuss the natural course and prognosis of IJO.
Main Methods:
- Diagnosis relies on excluding secondary causes of osteoporosis.
- Evaluation involves assessing bone fractures and overall health status.
- Literature review on existing therapeutic interventions for IJO.
Main Results:
- The etiology of IJO remains unknown.
- Treatment strategies include spinal protection, with sex steroids being contraindicated.
- Administered therapies like bisphosphonates, calcitriol, fluoride, and calcitonin yielded equivocal results.
- The condition typically undergoes spontaneous remission.
Conclusions:
- Idiopathic juvenile osteoporosis (IJO) is a diagnosis of exclusion in pediatric patients.
- Current treatments for IJO have limited efficacy, and management focuses on supportive care.
- The disease usually resolves on its own, emphasizing the importance of monitoring and protection.
Abstract:
Osteoporosis in childhood is uncommon, and it may be secondary to a spectrum of diverse conditions. When such causes have been excluded, some patients remain who have a congenital disease (osteoporosis imperfecta) or a disease in which the etiology is obscure, called idiopathic juvenile osteoporosis (IJO). The cause of IJO is unknown, and the diagnosis is based both on the exclusion of other diseases and on its own positive fractures. The basic strategy of treatment is to protect the spine until remission occurs. Sex steroids are contraindicated. Bisphosphonates, calcitriol, fluoride, and calcitonin have been administered therapeuticlly, but the results were equivocal. Usually the disease remits by itself.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
01:22The Functions of the Skeletal System
01:29Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:24Bone Formation by Endochondral Ossification